NMR based human gut metabolomic profiling reveals altered metabolites associated with pulmonary and extra-pulmonary tuberculosis
Authors:
- Vishal SharmaVSVishal Sharma
- Anoop SinghASAnoop Singh
- Sonam SharmaSSSonam Sharma
- Mohita GaurMGMohita Gaur
- Arun Kumar MalaisamyAMArun Kumar Malaisamy
- Deepti RawatDRDeepti Rawat
- Anjali YadavAYAnjali Yadav
- Bolaji Fatai OyeyemiBOBolaji Fatai Oyeyemi
- Aarushi VasudevaAVAarushi Vasudeva
- Anil ChaudhryACAnil Chaudhry
- Ashwani KhannaAKAshwani Khanna
- Vishal KhannaVKVishal Khanna
- 29 November 2025
- journal article
- research article
- Published by Springer Nature in Metabolomics
- Vol. 22 (1) , 1
Abstract
Introduction Tuberculosis remains one of the world’s deadliest infectious diseases. The pathophysiology of the two manifestations of Mycobacterium tuberculosis infection, pulmonary TB (PTB) and extrapulmonary TB (EPTB) is still not fully understood. Understanding the metabolic profile of both disease manifestations in patients is important for developing therapeutic approaches and molecular diagnosis. Objective The current study aimed to elucidate differences in the gut metabolic profile of PTB and EPTB patients compared to healthy controls (HCs). Method We used an untargeted approach through 1H Nuclear Magnetic Resonance (NMR) spectroscopy to perform metabolomic profiling of stool samples from 77 TB patients [pulmonary TB (PTB, n = 33), cervical lymph node TB (CrLNTB, n = 30), abdominal TB (ATB, n = 14)], and 30 HCs. Multivariate and univariate analyses were performed to identify the differential gut metabolites associated with TB patients. Results PTB patients showed greater metabolic perturbation than either EPTB group, with 24 metabolites significantly altered compared to 13 in ATB and 12 in CrLNTB, relative to HCs (adjusted p < 0.05). Each TB subtype displayed distinct metabolic profiles, yet several metabolites were commonly altered across all TB groups, including valine, N-formyl-L-methionine, choline, dimethylsulfone, tryptophan, valerate, N-acetylglutamate, creatine, and malonate. In the combined TB cohort versus controls, the most discriminatory metabolites were valine and N-formyl-L-methionine (AUC ≥ 0.80). Overall, these findings offer insights into the gut metabolome of TB patients in India and characterize for the first time metabolic perturbations in EPTB patients. Conclusion The study highlights the metabolic disruptions associated with PTB and EPTB patients.Keywords
Funding Information
- J. C. Bose research grant (B/S2/JCB-012/2015)
- The Institute of Eminence grant University of Delhi
This publication has 99 references indexed in Scilit:
- Tumor necrosis factor alpha in mycobacterial infectionSeminars in Immunology, 2014
- The Microbiome in Inflammatory Bowel Disease: Current Status and the Future AheadGastroenterology, 2014
- ¹H NMR-based metabolic profiling of human rectal cancer tissueMolecular Cancer, 2013
- Application of1H NMR Spectroscopy-Based Metabolomics to Sera of Tuberculosis PatientsJournal of Proteome Research, 2013
- Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy AdultsPLOS ONE, 2013
- A metagenome-wide association study of gut microbiota in type 2 diabetesNature, 2012
- Biomarkers of Inflammation, Immunosuppression and Stress Are Revealed by Metabolomic Profiling of Tuberculosis PatientsPLOS ONE, 2012
- 1H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiomeNMR in Biomedicine, 2007
- Mass spectrometry‐based metabolomicsMass Spectrometry Reviews, 2006
- Tumor necrosis factor-α and muscle wasting: a cellular perspectiveRespiratory Research, 2001